This study found that APP/PS1 mice receiving a transplant of the gut microbiome from an AD patient had increased expression of Nlrp3 in their intestinal tract and increased levels of inflammatory factors such as IL-1β and IL-6 in their peripheral blood (62). The gene discussed is NLRP3; the disease is Alzheimer disease.